Amends the definitions of diagnostic pharmaceuticals, topical therapeutic pharmaceutical agents, and therapeutic pharmaceutical agents for treatment of glaucoma and ocular hypertension as they relate to the certification to use therapeutic drugs in the practice of optometry.
Summary
Bill S00621 seeks to amend the New York Education Law regarding the definitions and usage of various pharmaceutical agents in optometry. Specifically, it revises the definitions of diagnostic pharmaceuticals, topical therapeutic pharmaceutical agents, and therapeutic pharmaceutical agents used for treating glaucoma and ocular hypertension. The bill aims to clarify the types of drugs that optometrists can use and prescribe, ensuring that they are limited to those that are FDA approved and commercially available for topical application to the eye and its surrounding areas.
Impact
If enacted, this bill will update the legal framework governing the practice of optometry in New York, particularly concerning the use of pharmaceutical agents. It will allow certified optometrists to have clearer guidelines on the types of drugs they can prescribe, potentially enhancing patient care and treatment outcomes for conditions such as glaucoma and ocular hypertension. The amendments will also ensure that the definitions align with current medical practices and standards.
Sentiment
The sentiment surrounding Bill S00621 appears to be neutral, as there have been no recorded votes or significant committee discussions that indicate strong support or opposition. The lack of contention in the legislative history suggests that the bill may be seen as a necessary update to existing laws rather than a controversial change.
Contention
There are no notable points of contention reported in the discussions or voting history related to Bill S00621. The bill seems to be straightforward in its intent to clarify and modernize the definitions of pharmaceutical agents used in optometry, which may contribute to its lack of opposition.
Same As
Amends the definitions of diagnostic pharmaceuticals, topical therapeutic pharmaceutical agents, and therapeutic pharmaceutical agents for treatment of glaucoma and ocular hypertension as they relate to the certification to use therapeutic drugs in the practice of optometry.